OriGene Technologies is a research tool company commercializing products and services in the life science and clinical diagnostic segments, in the US, China and Europe. It currently owns the largest commercial collection of full-length human cDNAs in a standard expression vector.
OriGene's vision is to enable scientists and clinicians to study complete biological pathways, thus allowing a better understanding of disease mechanisms including in cancer and stem cell research.
Exit Date: 2016
Life Science Tools, MedTech & Diagnostics
Investment’s Exit Date